AAAAAA

   
Results: 1-15 |
Results: 15
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
Authors: Amabile, M Gannini, B Testoni, N Montefusco, V Rosti, G Zardini, C Terragna, C Buonamici, S Ottaviani, E Soverini, M Fiacchini, M Bassi, S de Vivo, A Trabacchi, E Saglio, G Pane, F Baccarani, M Tura, S Martinelli, G
Citation: M. Amabile et al., Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia, HAEMATOLOG, 86(3), 2001, pp. 252-259
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response
Authors: Martinelli, G Montefusco, V Amabile, M Lemoli, RM Terragna, C Testoni, N Ottaviani, E Rosti, G De Vivo, A Rizzi, S Russo, D Bregoli, M Tura, S
Citation: G. Martinelli et al., Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response, LEUK LYMPH, 39(1-2), 2000, pp. 113-120
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Motta, MR Testoni, N Amabile, M Ottaviani, E Vianelli, N de Vivo, A Gozzetti, A Tura, S Cave, M
Citation: G. Martinelli et al., Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma, J CL ONCOL, 18(11), 2000, pp. 2273-2281
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Testoni, N Amabile, M Ottaviani, E Buonamici, S Soverini, S Montefusco, V De Vivo, A Bonifazi, F Tura, S Cavo, M
Citation: G. Martinelli et al., Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation, HAEMATOLOG, 85(9), 2000, pp. 930-934
Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation
Authors: Martinelli, G Montefusco, V Testoni, N Amabile, M Saglio, G Ottaviani, E Terragna, C Bonifazi, F Rosti, G Bandini, G Tura, S
Citation: G. Martinelli et al., Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation, HAEMATOLOG, 85(6), 2000, pp. 653-658
Alu and translisin recognition site sequences flanking translocation sitesin a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints
Authors: Martinelli, G Terragna, C Amabile, M Montefusco, V Testoni, N Ottaviani, E de Vivo, A Mianulli, A Saglio, G Tura, S
Citation: G. Martinelli et al., Alu and translisin recognition site sequences flanking translocation sitesin a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints, HAEMATOLOG, 85(1), 2000, pp. 40-46
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy
Authors: Martinelli, G Testoni, N Amabile, M Bonifazi, F De Vivo, A Farabegoli, P Terragna, C Montefusco, V Ottaviani, E Saglio, G Russo, D Baccarani, M Rosti, G Tura, S
Citation: G. Martinelli et al., Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy, BONE MAR TR, 25(7), 2000, pp. 729-736
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
Authors: Cavo, M Terragna, C Martinelli, G Ronconi, S Zamagni, E Tosi, P Lemoli, RM Benni, M Pagliani, G Bandini, G Tura, S
Citation: M. Cavo et al., Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma, BLOOD, 96(1), 2000, pp. 355
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy
Authors: Lemoli, RM Martinelli, G Zamagni, E Motta, MR Rizzi, S Terragna, C Rondelli, R Ronconi, S Curti, A Bonifazi, F Tura, S Cavo, M
Citation: Rm. Lemoli et al., Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy, BLOOD, 95(7), 2000, pp. 2234-2239
Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient
Authors: Martinelli, G Amabile, M Terragna, C Testoni, N Ottaviani, E Montefusco, V de Vivo, A Baccarani, M Ricci, P Saglio, G Tura, S
Citation: G. Martinelli et al., Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient, LEUKEMIA, 13(9), 1999, pp. 1463-1464
Translisin recognition site sequences flank translocation breakpoints in aPhiladelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)
Authors: Martinelli, G Terragna, C Amabile, M Montefusco, V Testoni, N Ottaviani, E de Vivo, A Mianulli, A Trabacchi, E Saglio, G Tura, S
Citation: G. Martinelli et al., Translisin recognition site sequences flank translocation breakpoints in aPhiladelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2), LEUKEMIA, 13(10), 1999, pp. 1635-1637
An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia
Authors: Amabile, M Martinelli, G Terragna, C Montefusco, V Tabilio, A Tura, S
Citation: M. Amabile et al., An atypical (b3/a3) junction of the bcr/abl gene lacking abl exon a2 in a patient with chronic myeloid leukemia, HAEMATOLOG, 84(6), 1999, pp. 573-575
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34(+) stem cells
Authors: Martinelli, C Terragna, C Lemoli, RM Cavo, M Benni, M Motta, MR Amabile, M Ottaviani, E Testoni, N De Vivo, A Tura, S
Citation: C. Martinelli et al., Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34(+) stem cells, HAEMATOLOG, 84(5), 1999, pp. 397-404
Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures
Authors: Martinelli, G Ottaviani, E Testoni, N Visani, G Terragna, C Amabile, M Trabacchi, E Montefusco, V Tura, S
Citation: G. Martinelli et al., Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures, BONE MAR TR, 24(6), 1999, pp. 694-697
Selection and transplantation of autologous CD34(+) B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study
Authors: Lemoli, MR Martinelli, G Olivieri, A Motta, MR Rizzi, S Terragna, C Leopardi, G Benni, M Ronconi, S Cantori, I Rondelli, D Mangianti, S Leoni, P Montanari, M Cavo, M Tura, S
Citation: Mr. Lemoli et al., Selection and transplantation of autologous CD34(+) B-lineage negative cells in advanced-phase multiple myeloma patients: a pilot study, BR J HAEM, 107(2), 1999, pp. 419-428
Risultati: 1-15 |